🇺🇸 FDA

Drug profile · INN

sulfacetamide sodium

KLARON

approved
US status
approved
Patents linked
8
News articles
0

Quick answer

sulfacetamide sodium (KLARON) is an FDA-listed pharmaceutical active ingredient. Route of administration: ophthalmic. Current US regulatory status: approved.

Key facts

INN sulfacetamide sodium
Brand KLARON
Route OPHTHALMIC
Formulation LOTION

Related patents

Search patents →

  1. US 12247004

    2-amino-N-(amino-oxo-aryl-lambda6-sulfanylidene)acetamide compounds and their therapeutic use

    Expires Mon Mar 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11802110

    2-amino-N-(arylsulfinyl)-acetamide compounds as inhibitors of bacterial aminoacyl-tRNA synthetase

    Expires Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11241415

    N-methyl-N-(1-phenyl-2-(1-pyrrolidinyl)ethyl)-2-aminophenylacetamide derivatives agonists for the κ opioid receptor

    Expires Mon Feb 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10322107

    N-methyl-N-(1-phenyl-2-(1-pyrrolidinyl)ethyl)-2-aminophenylacetamide derivatives agonists for the kappa opioid receptor

    Expires Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8980887

    2-aryl imidazo[1,2-a]pyridine-3-acetamide derivatives, preparation methods and uses thereof

    Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7459458

    Polymorph of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto

    Expires Mon Nov 27 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7410979

    Synergistically effective combinations of dihaloacetamide compounds and interferon or ribavirin against HCV infections

    Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7348429

    Process for purifying N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide(zaleplon) and crystalline forms of zaleplon accessible with the process

    Expires Mon Mar 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is sulfacetamide sodium?

sulfacetamide sodium (KLARON) is an FDA-listed pharmaceutical active ingredient. Route of administration: ophthalmic. Current US regulatory status: approved.

What is the brand name for sulfacetamide sodium?

KLARON is a marketed brand name for sulfacetamide sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of sulfacetamide sodium?

sulfacetamide sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.